Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Evaluate the Use of the Minder Device to Aid in Developing a Treatment Plan After Inconclusive Prolonged EEG in Patients With Epilepsy

NCT07110337 is registered in ClinicalTrials.gov with Epiminder America, Inc. as lead sponsor.

NCT NCT07110337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07110337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Evaluate the Use of the Minder Device to Aid in Developing a Treatment Plan After Inconclusive Prolonged EEG in Patients With Epilepsy
Lead sponsor
Epiminder America, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
December 23, 2025
Completion date
June 30, 2027
Enrollment
210 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, epilepsy (treatment refractory)